Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PD 0332991 in Recurrent Rb Positive Glioblastoma
NCT01227434Phase 2Terminated
- Sponsor
- University of California, San Francisco
- Start
- Sep 2010
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of palbociclib in glioblastoma (GBM), Gliosarcoma (GS), sponsored by University of California, San Francisco. Started Sep 2010; status: terminated.
02
Drugs
palbociclib
03
Conditions
glioblastoma (GBM)Gliosarcoma (GS)
Beyond the preview
Go deeper on NCT01227434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01227434.